Virtual Advisory Boards

Virtual Advisory Boards

MphaR Our Services Virtual Advisory Boards
Virtual Advisory Boards (VABs) provide a flexible, efficient, and insight-rich way to engage experts across geographies. MphaR supports the full design, coordination, and delivery of virtual advisory engagements —ranging from live, synchronous sessions to fully asynchronous formats—ensuring meaningful scientific dialogue and high-quality outcomes.
Our approach enables companies to gather deeper, more diverse insights while eliminating logistical constraints and enhancing global participation.

Get Some Ideas for Creating a Perfect Event

Live Virtual Advisory Boards

Real-time meetings that allow direct discussion, debate, and interactive exchange between advisors and moderators.

Asynchronous Virtual Advisory Boards (AVAB)

Structured online discussions that run continuously over several days or weeks—allowing advisors to contribute thoughtfully, at their own pace, from anywhere in the world.

Hybrid / Mixed Approach

Our MphaR Virtual Advisory Board Platform combines synchronous and asynchronous components, offering the best of both worlds.

This blended model supports more meaningful, reflective contributions and increases overall engagement.

The MphaR Virtual Advisory Board Platform

Our proprietary digital platform is designed specifically for scientific engagement, giving Medical Affairs teams a secure, compliant, and highly interactive environment for virtual advisory activities.

Platform Features :

  • Discussion forums for structured, topic-based dialogue 
  • Breakout sessions for small-group expert discussions 
  • Live video calls integrated directly into the platform 
  • Interactive workshops for collaborative analysis and problem-solving 
  • Polling & surveys to quantify opinions and generate evidence-driven insights 
  • Document annotation & co-creation tools for reviewing manuscripts, slides, and publications 
  • Meeting board functionality allowing real-time idea sharing, prioritization, and clustering 

24/7 Expert Engagement

Advisors and moderators can participate anytime, anywhere, with: 

Designed for Deeper, More Meaningful Insights

Virtual engagement encourages:
  • Reflection and more nuanced contributions
  • Broader participation from experts with limited travel availability
  • Real-time collaboration on documents, data, and clinical questions
  • A higher volume of insights than traditional in-person-only boards

Wide Stakeholder Inclusion

Our Virtual Advisory Boards can include a diverse set of stakeholders, such as:
  • Physicians
  • Pathologists
  • Pharmacists
  • Clinical pharmacologists
  • Nurses / Advanced Practice Providers (APPs)
  • Government officials
  • Patient Advocacy Groups (PAGs)
This ensures multidisciplinary perspectives are captured for a more complete, real-world view.

Case Studies

Planned F2F Advisory Board on Non-Small Cell Lung Cancer (NSCLC) Switched to Virtual Format

Top-Notch Advisory Board in Metastatic Breast Cancer Executed in Virtual Format

Hemophdia a Virtual Advisory Board with Patient Advocacy (PAGS)

Virtual Advisory Board with Payers

Improving the Treatment Care of Patients with Multiple Myeloma Through Regular Connection between International and National Rheumatologists in…

NSCLC Virtual Advisory Board with Global Oncologists

What Makes Our Strategy Support Unique?

What HCPs and Medical Affairs Experts Tell About Working with Us

We work closely with HCPs and Medical Affairs experts worldwide. Here’s what they share about partnering with MphaR
Trusted by Industry Leaders

Medical Affairs Trends: Blog, Digest and Podcasts

Stay informed on emerging Medical Affairs trends with expert blog articles, and twice-monthly editions of our Medical Affairs Digest and podcasts series.

TrendWatch: Medical Affairs

Explore concise articles covering the latest trends and innovations in Medical Affairs

Latest Article

Digital Preceptorships: Medical Affairs Takes Training Beyond the Hospital

The article explains how clinical training is shifting from traditional, hospital‑based preceptorships to hybrid and fully digital models that enable continuous, scalable expert learning. As digital platforms, virtual case discussions, and simulation technologies mature, preceptorships evolve from limited in‑person visits into ongoing, accessible educational ecosystems. By expanding beyond geographic and scheduling constraints, digital preceptorships allow clinicians to engage with expert faculty through structured virtual cases, remote mentorship, and interactive learning modules. This transforms what was once a one‑time observational experience into continuous knowledge exchange that supports real‑world clinical decision-making. Supported by Medical Affairs leadership, coordinated program design, and partnerships with clinical experts, digital preceptorships integrate consistent curricula, advanced analytics, and hybrid engagement pathways. These elements turn fragmented training opportunities into sustained professional development — positioning Medical Affairs as a key enabler of global clinical education and long-term competency building.

Augmented Intelligence, Not Artificial: How Medical Affairs and AI Work Together

The article explains how Medical Affairs is transitioning from manual data processing to an augmented intelligence model that blends AI-driven analytics with human scientific judgment. As automated literature review, trend detection, and digital insight platforms advance, MA evolves from reactive data handling into a continuous, high‑value scientific interpretation function. By allowing AI to synthesize large evidence volumes, surface emerging themes, and accelerate content preparation, augmented intelligence shifts MA effort from information gathering to contextual evaluation, strategic reasoning, and ethical decision-making. This partnership model enhances the ability to understand evolving scientific landscapes and respond to stakeholder needs with greater speed and depth. Supported by secure digital environments, structured expert engagement, and responsible AI oversight, augmented intelligence converts disparate data streams into sustained insight generation. As a result, Medical Affairs strengthens its role as a strategic scientific partner—guiding evidence planning, enabling more informed communication, and building long-term trust across the healthcare ecosystem.

Medical Affairs at Congresses: Turning Live Meetings into Continuous Scientific Exchange

The article explains how Medical Affairs is redefining congress participation from a concentrated, event-based activity into a continuous, multi-phase scientific exchange. As digital tools, hybrid formats, and data analytics mature, congresses evolve from isolated gatherings into catalysts for sustained engagement. By activating stakeholders before meetings, capturing structured real-time insights onsite, and extending dialogue through post-congress follow-up, Medical Affairs transforms fleeting interactions into enduring knowledge assets. Supported by AI-enabled synthesis, coordinated cross-functional alignment, and longitudinal impact measurement, congress strategy shifts from short-term presence to ongoing scientific partnership—positioning Medical Affairs as a driver of continuous insight generation and long-term stakeholder trust.

Bi-monthly Newsletter: Medical Affairs Digest

Your bi-monthly overview of essential Medical Affairs updates and emerging industry signals

Latest Newsletter
Bi-Monthly podcasts: Medical Affairs Voices

Listen to expert conversations exploring current trends and future directions in Medical Affairs

Precision Medicine in Oncology: Transforming Cancer Diagnostics Using AI Tools

In this episode, we uncover how artificial intelligence is transforming oncology, marking a shift from standardizedtreatments to precision medicine tailored to each patient’s genetic and molecular profile. From AI-powered imaging and digital pathology to genomic analysis and liquid biopsies, technology is reshaping how cancer is detected, understood, and treated. Hear how these innovations are driving earlier diagnoses, improving treatment accuracy, and empowering clinicians with insights once thought impossible. We also explore the ethical and practical challenges of integrating AI into cancercare and what it means for patients and providers alike. Join us as we look ahead to a future where AI doesn’t replace the human touch—it amplifies it, bringing us closer to truly personalized oncology care.

Leveraging AI and NLP to Transform Medical Information Systems in Medical Affairs

In this episode, we explore how artificial intelligence and natural language processing are reshaping how Medical Affairs teams manage, interpret, and apply vast volumes of unstructured medical information. From scientific literature and safety reports to advisory board insights and field intelligence, NLP is turning free text into structured, actionable knowledge—helping teams move faster while maintaining scientific rigor. Discover how NLP is being applied across literature intelligence, medical information systems, pharmacovigilance, and stakeholder engagement, and why human oversight remains essential in regulated medical environments. We also examine the risks, ethical considerations, and governance frameworks needed to ensure accuracy, transparency, and compliance. Join us as we look ahead to the evolution from language processing to true language understanding—and what this shift means for the future of Medical Affairs as a strategic, insight-driven function.

From Data to Dialogue — Strengthening Patient-Centricity Through Virtual Advisory Boards

In this episode, we examine how Virtual Advisory Boards are revolutionizing patient engagement, turning static data into meaningful dialogue that shapes real-world decisions. As patient-centricity becomes a defining principle in modern pharma, digital platforms are creating space for authentic collaboration between patients, caregivers, and industry leaders. Discover how virtual formats remove barriers to participation, ensure inclusivity, and make continuous patient input a practical reality. We’ll explore how the MphaR Virtual Advisory Board platform enables companies to integrate patient insights into trial design, treatment strategies, and beyond. Tune in as we explore how the future of patient engagement is being built—one conversation at a time—through innovation, empathy, and dialogue that truly puts patients at the center of healthcare.

Follow MphaR on Social Media:

MphaR Our Services Virtual Advisory Boards

FAQs

Yes, this is one of the most requested deliverables? We also facilitate the session if needed.
In urgent cases, 2-3 weeks. Standard timelines: 8-12 weeks.
Yes. We provide structured insights. Key takeaways and recommended actions are clearly highlighted.
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure